Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,149 | -13,259 | -6,492 | -22,499 | -16,690 |
| Depreciation Amortization | 469 | 324 | 134 | 429 | 314 |
| Accounts payable and accrued liabilities | 340 | 515 | 726 | -710 | 141 |
| Other Working Capital | 700 | -997 | -748 | -341 | -587 |
| Other Operating Activity | 3,546 | 2,055 | 515 | 4,340 | 2,558 |
| Operating Cash Flow | $-16,094 | $-11,362 | $-5,865 | $-18,781 | $-14,264 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,273 | 13,266 | 2,754 | 6,266 | 8,331 |
| PPE Investments | -4,748 | -902 | -332 | -952 | -838 |
| Investing Cash Flow | $525 | $12,364 | $2,422 | $5,314 | $7,493 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 52,508 | 29,164 | 16,622 | 162 | 90 |
| Financing Cash Flow | $52,508 | $29,164 | $16,622 | $162 | $90 |
| Beginning Cash Position | 6,687 | 6,687 | 6,687 | 19,992 | 19,992 |
| End Cash Position | 43,626 | 36,853 | 19,866 | 6,687 | 13,311 |
| Net Cash Flow | $36,939 | $30,166 | $13,179 | $-13,305 | $-6,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,094 | -11,362 | -5,865 | -18,781 | -14,264 |
| Capital Expenditure | -4,748 | -902 | -332 | -952 | -838 |
| Free Cash Flow | -20,842 | -12,264 | -6,197 | -19,733 | -15,102 |